Skystar Bio-Pharmaceutical Stock Price, News & Analysis (OTCMKTS:SKBI)

Previous Close$0.01
Today's RangeN/A
52-Week RangeN/A
Volume9,000 shs
Average Volume1,082 shs
Market Capitalization$90,000.00
P/E RatioN/A
Dividend YieldN/A
Beta42.76

About Skystar Bio-Pharmaceutical (OTCMKTS:SKBI)

Skystar Bio-Pharmaceutical Co., Ltd. is a manufacturer and distributor of veterinary medicines and healthcare products in China. The Company develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine (TCM); topicals, supplements, probiotics, and diagnostic kits and animal, animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets within China. The Company operates four product lines: Probiotics, Veterinary Medicine, Veterinary Vaccines and Feed Additives. The Company provides a range of veterinary products serving regional micro-farms offering, such as Veterinary vaccines, including aquaculture, Veterinary medicines, Pro-biotic microorganisms and Animal feed additives. The Company's Veterinary drug products include Ivermectin Premix, Feizhu San, Tilmicosin Premix, Stimulated egg powder, Wulingsan, Yimu Shenghua San, Qingwen Baidu San and Spectinomycin Hydrochloride Injection.

Receive SKBI News and Ratings via Email

Sign-up to receive the latest news and ratings for SKBI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:SKBI
CUSIPN/A
Phone86-29-8819-3188

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares8,700,000

Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Frequently Asked Questions

What is Skystar Bio-Pharmaceutical's stock symbol?

Skystar Bio-Pharmaceutical trades on the OTCMKTS under the ticker symbol "SKBI."

Who are some of Skystar Bio-Pharmaceutical's key competitors?

Who are Skystar Bio-Pharmaceutical's key executives?

Skystar Bio-Pharmaceutical's management team includes the folowing people:

  • Weibing Lu, Chairman of the Board, Chief Executive Officer (Age 51)
  • Bing Mei, Chief Financial Officer (Age 51)
  • Wei Wen, Secretary, Director (Age 46)
  • R. Scott Cramer, Director (Age 50)
  • Mark D. Chen, Independent Director (Age 47)
  • Qiang Fan, Independent Director (Age 58)
  • Chengtun Qu, Independent Director (Age 48)
  • Weirong Shen, Independent Director (Age 48)

How do I buy Skystar Bio-Pharmaceutical stock?

Shares of Skystar Bio-Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is Skystar Bio-Pharmaceutical?

Skystar Bio-Pharmaceutical has a market capitalization of $90,000.00.

How can I contact Skystar Bio-Pharmaceutical?

Skystar Bio-Pharmaceutical's mailing address is RM 10601 JIEZUO PLAZA NO. 4 FENGHUI ROAD SOUTH, XIAN F4, . The healthcare company can be reached via phone at 86-29-8819-3188 or via email at [email protected]


MarketBeat Community Rating for Skystar Bio-Pharmaceutical (SKBI)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  35 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Skystar Bio-Pharmaceutical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Earnings History and Estimates Chart

Earnings by Quarter for Skystar Bio-Pharmaceutical (OTCMKTS:SKBI)

Skystar Bio-Pharmaceutical (OTCMKTS SKBI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2014Q413$0.13$5.53 million$6.83 millionViewN/AView Earnings Details
11/15/2013Q313$0.49$8.93 million$15.99 millionViewN/AView Earnings Details
8/15/2013Q1 2013$0.49$8.90 million$11.30 millionViewN/AView Earnings Details
5/16/2013Q113$0.09$7.93 million$5.53 millionViewN/AView Earnings Details
11/15/2012Q312$0.36$20.90 million$8.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Skystar Bio-Pharmaceutical (OTCMKTS:SKBI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Skystar Bio-Pharmaceutical (OTCMKTS SKBI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 19.80%
Insider Trades by Quarter for Skystar Bio-Pharmaceutical (OTCMKTS:SKBI)

Skystar Bio-Pharmaceutical (OTCMKTS SKBI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2015John M GregoryMajor ShareholderBuy63,900$2.91$185,949.00View SEC Filing  
5/6/2015John M GregoryMajor ShareholderBuy50,000$3.47$173,500.00View SEC Filing  
4/16/2015John M GregoryMajor ShareholderBuy35,000$3.82$133,700.00View SEC Filing  
2/2/2015John M GregoryMajor ShareholderBuy38,730$4.21$163,053.30View SEC Filing  
12/23/2014John M GregoryMajor ShareholderBuy70,800$4.28$303,024.00View SEC Filing  
12/10/2014John M GregoryMajor ShareholderBuy103,016$4.56$469,752.96View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Skystar Bio-Pharmaceutical (OTCMKTS SKBI) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Skystar Bio-Pharmaceutical (OTCMKTS SKBI) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.